<DOC>
	<DOCNO>NCT00601263</DOCNO>
	<brief_summary>The purpose study determine safety anti-asthma herbal medicine intervention ( ASHMI ) adult asthmatic see effect ASHMI certain part immune system .</brief_summary>
	<brief_title>Safety Study Chinese Herbal Therapy Treat Asthma</brief_title>
	<detailed_description>Asthma major public health problem worldwide , particularly westernized society continue increase prevalence past two decade . Inhaled corticosteroid become first-line treatment persistent asthma even though significant side effect report . New asthma medication , include leukotriene inhibitor anti-IgE , show marginal benefit . Patients increasingly turn complementary alternative medicine ( CAM ) treatment asthma , despite uncertainty benefit due lack well-controlled scientific study . We develop Chinese herbal formula compose 3 herb call ASHMI . It previously show murine study ASHMI ( formula contain Ling Zhi , Ku Shen Gan Cao ) therapeutic effect major pathogenic mechanism asthma-airway hyperreactivity , pulmonary inflammation , airway remodel , well down-regulating TH2 response . A subsequent study 91 asthmatic patient Weifang , China find ASHMI safe effective alternative prednisone treat asthma exhibit beneficial effect TH1 TH2 balance . Based preliminary study , hypothesize ASHMI safe medication atopic patient asthma lead identifiable change serum immunologic marker .</detailed_description>
	<mesh_term>Asthma</mesh_term>
	<criteria>Male female subject age 1840 otherwise good health determine medical history physical examination History asthma document physician Documentation allergy two common environmental allergen evidence positive prick skin RAST test The subject agree participate study Females childbearing potential must inactive sexually take effective birth control measure , deem appropriate investigator , duration study . Acute illness ( cold , flu , etc . ) within one week administration study drug Any history systemic disease investigator 's opinion would preclude subject participate study , include viral hepatitis infection ( patient selfreport ) Abnormal hepatic function Abnormal bone marrow function Abnormal renal function Clinically significant abnormal electrocardiogram Current uncontrolled moderate severe asthma FEV1 &lt; 80 % predicted Participation another experimental study within 30 day study History alcohol drug abuse ( self report ) Pregnant lactate female subject . Females childbearing potential need negative serum pregnancy test consider study Current smoker</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>December 2009</verification_date>
	<keyword>Chinese Herbal Therapy</keyword>
	<keyword>Asthma</keyword>
	<keyword>Investigational new drug ( IND )</keyword>
	<keyword>Complementary Alternative Medicine</keyword>
</DOC>